| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $1,040,098 ) |
| | 2025 | 2025 | FLEXOMICS LLC | 764 MAIN ST | WALTHAM | MA | 02451-0603 | MIDDLESEX | USA | R44HG013448 | A novel flexible approach for high-throughput single-cell phenotyping and genotyping | 000 | 2 | NIH | 1/16/2025 | $1,040,098 |
|
| Issue Date FY: 2024 ( Subtotal = $1,009,871 ) |
| | 2024 | 2024 | FLEXOMICS LLC | 764 MAIN ST | WALTHAM | MA | 02451-0603 | MIDDLESEX | USA | R44HG013448 | A novel flexible approach for high-throughput single-cell phenotyping and genotyping | 000 | 1 | NIH | 2/9/2024 | $1,009,871 |
|
| Issue Date FY: 2023 ( Subtotal = $846,678 ) |
| | 2023 | 2023 | FLEXOMICS LLC | 764 MAIN ST | WALTHAM | MA | 02451-0603 | MIDDLESEX | USA | R44CA250673 | Novel Approach to High-Throughput Identification and Characterization of Neoantigen-Specific T-Cell Receptors to Guide Immunotherapy Development. | 000 | 3 | NIH | 6/19/2023 | $846,678 |
|
| Issue Date FY: 2022 ( Subtotal = $1,202,794 ) |
| | 2022 | 2022 | FLEXOMICS LLC | 38 WAREHAM ST | BOSTON | MA | 02118-2861 | SUFFOLK | USA | R44CA250673 | Novel Approach to High-Throughput Identification and Characterization of Neoantigen-Specific T-Cell Receptors to Guide Immunotherapy Development. | 000 | 2 | NIH | 6/23/2022 | $1,202,794 |
| | 2022 | 2022 | FLEXOMICS LLC | 38 WAREHAM ST | BOSTON | MA | 02118-2861 | SUFFOLK | USA | R44CA250673 | Novel Approach to High-Throughput Identification and Characterization of Neoantigen-Specific T-Cell Receptors to Guide Immunotherapy Development. | 001 | 2 | NIH | 9/14/2022 | $0 |
| | 2022 | 2020 | FLEXOMICS LLC | 38 WAREHAM ST | BOSTON | MA | 02118-2861 | SUFFOLK | USA | R43CA250673 | Novel Approach to High-Throughput Identification and Characterization of Neoantigen-Specific T-Cell Receptors to Guide Immunotherapy Development. | 000 | 1 | NIH | 9/14/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $0 ) |
| | 2021 | 2020 | FLEXOMICS LLC | 38 WAREHAM ST FL 3 | BOSTON | MA | 02118-2861 | SUFFOLK | USA | R43CA250673 | Novel Approach to High-Throughput Identification and Characterization of Neoantigen-Specific T-Cell Receptors to Guide Immunotherapy Development. | 000 | 1 | NIH | 3/26/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $399,807 ) |
| | 2020 | 2020 | FLEXOMICS LLC | 38 WAREHAM ST FL 3 | BOSTON | MA | 02118-2861 | SUFFOLK | USA | R43CA250673 | Novel Approach to High-Throughput Identification and Characterization of Neoantigen-Specific T-Cell Receptors to Guide Immunotherapy Development. | 000 | 1 | NIH | 6/15/2020 | $399,807 |
|
|
